Peng Qi | Biochemistry | Editorial Board Member

Published on by Medical Lab Scientist

Prof. Dr. Peng Qi | Biochemistry | Editorial Board Member

Professor | Institute of Oceanology, Chinese Academy of Sciences | China

Dr. Peng Qi is a senior researcher at the Institute of Oceanology, Chinese Academy of Sciences, whose scholarly work focuses on corrosion science and marine biofouling, with particular emphasis on material degradation and protection in complex ocean environments. His research integrates experimental investigations and applied materials science to advance the understanding of corrosion mechanisms, antifouling strategies, and durability of marine infrastructures. Prof. Qi has made sustained contributions to the development of innovative approaches for mitigating corrosion and biofouling, supporting both fundamental science and real-world marine engineering applications. His scientific output comprises 60 peer-reviewed documents, reflecting consistent productivity and influence in the field. These works have collectively received 1,969 citations, underscoring their impact and recognition within the global research community. With an h-index of 23, his publications demonstrate both depth and continuity of contribution, positioning him as an established authority in marine corrosion and biofouling research.

Citation Metrics (Scopus)

2000

1500

1000

500

0

 

1,969
Citations

60
Documents

23
h-index

Citations

Documents

h-index

Featured Publications

Guoping Zhou | Biochemistry | Research Excellence Award

Published on by Medical Lab Scientist

Prof. Dr. Guoping Zhou | Biochemistry | Research Excellence Award

Professor | Rocky Mount Life Science Institute | United States

Dr. Guoping Zhou is a distinguished researcher recognized for seminal contributions to structural biology, biophysics, and medicinal chemistry. His research focuses on elucidating protein–protein, protein–DNA, and protein–drug interactions using solution NMR spectroscopy, molecular modeling, and bioinformatics. He has advanced the understanding of protein misfolding mechanisms, polysialyltransferase function, and neural cell adhesion molecule (NCAM) polysialylation, providing structural insights with translational relevance to drug discovery. A notable contribution is the integration of Wenxiang diagrams with NMR data to interpret complex biomolecular interactions. His work includes NMR-determined structures deposited in the Protein Data Bank and influential studies published in high-impact journals across biochemistry, structural biology, and medicinal chemistry. With 4,789 citations, an h-index of 31, and an i10-index of 42, his scholarly output reflects sustained impact and leadership in advancing molecular-level understanding of biological systems through innovative structural and computational approaches.

Citation Metrics (Scopus)

4000

3000

2000

1000

0

 

3613
Citations

56
Documents

27
h-index

Citations

Documents

h-index

Featured Publications

Teresa De Diego Puente | Biochemistry | Excellence in Research Award

Published on by Medical Lab Scientist

Prof. Dr. Teresa De Diego Puente | Biochemistry | Excellence in Research Award

Professor | University of Murcia | Spain

Dr. Teresa de Diego Puente is an internationally recognized researcher whose work advances biocatalysis, synthetic biology, and molecular systems biology, with a strong emphasis on sustainable biotechnology and systems-level regulation in microbial cell factories. Her research has delivered foundational contributions to green chemistry through enzyme catalysis in non-conventional media and has evolved toward the engineering of Escherichia coli as a robust platform for biotransformations and recombinant production. She has led influential studies on protein acetylation, metabolic flux regulation, and omics-driven optimization of bacterial networks, providing mechanistic insights with direct relevance to industrial biotechnology and biopharmaceutical manufacturing. Her scholarly output comprises 60 documents, which have collectively received 3,050 citations, reflecting sustained international impact and visibility across interdisciplinary fields. With an h-index of 26, her work demonstrates both productivity and citation depth, positioning her research among well-cited and methodologically influential contributions to modern biotechnology and systems biology.

Citation Metrics (Scopus)

3500
2500
1500
500
0

3,050
Citations

60
Documents

26
h-index

Citations

Documents

h-index

Featured Publications

Peter Delannoy | Biochemistry | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Peter Delannoy | Biochemistry | Research Excellence Award

Independent Scientist | Origins of Human Metabolic Disease | United States

Dr. Peter Delannoy is a research-focused scientist whose scholarly work is centered on biochemistry and chemistry education, with contributions that integrate molecular science, analytical reasoning, and applied scientific methodologies. His research output reflects a targeted and concise academic profile, comprising 1 peer-reviewed document, which has accumulated 3 citations, resulting in an h-index of 1. His scholarly activity emphasizes knowledge synthesis, experimental interpretation, and the translation of biochemical principles into structured scientific frameworks. Through his documented research contribution, he demonstrates engagement with foundational biochemical concepts and their relevance to broader scientific inquiry. His citation record indicates early but measurable academic impact, while his h-index reflects consistent alignment between publication output and scholarly recognition. Overall, his research profile represents a focused academic trajectory grounded in biochemistry and chemistry, contributing incrementally to the scientific literature through rigorously developed and cited work.

Citation Metrics (Scopus)

4
3
2
1
0

3

Citations

1
Documents

1
h-index

Citations

Documents

h-index

Featured Publication


Aldose reductase, fructose and fat production in the liver

Biochemical Journal, 2025
Delannoy P., Tolan D. R., Lanaspa M. A., San Millán I., Bae S. Y., Johnson R. J.

Cara-Lynne Schengrund | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Cara-Lynne Schengrund | Biochemistry | Best Researcher Award

Professor | Penn State College of Medicine | United States

Dr. Cara-Lynne Schengrund, Professor Emerita of Biochemistry and Molecular Biology at the Pennsylvania State University College of Medicine, is a distinguished scientist whose career has spanned over four decades. She earned her B.S. in Chemistry from Upsala College and her M.S. and Ph.D. In Chemistry from Seton Hall University, later holding research positions at Columbia University before joining Penn State. Rising through the academic ranks, she served as Assistant Professor, Associate Professor, Professor, and Acting Department Chair, ultimately achieving Emerita status. Her pioneering research has focused on glycosphingolipids and gangliosides, where she made landmark discoveries on their roles in neuronal development, neuroblastoma prognosis, and lipid raft biology, as well as their function as receptors for bacterial toxins and viruses. Her laboratory was the first to develop multivalent oligosaccharide inhibitors that block cholera toxin and HIV binding, establishing new therapeutic strategies. She has also contributed groundbreaking insights into the roles of gangliosides and cholesterol in Alzheimer’s disease and autism, authoring over 200 influential publications in neurochemistry and glycobiology. Beyond research, Dr. Schengrund has been a leader in academic service, serving as Chair of the Penn State Faculty Senate, elected Council Member of the American Society for Neurochemistry, and as a member of NIH and VA study sections. Her honors include the Distinguished Alumni Award from Upsala College and the YWCA Tribute to Women of Excellence. Through her research, mentorship, and leadership, Dr. Schengrund has made a lasting impact on science, medicine, and education.

Profile: ORCID

Featured Publications

Mingjie Wei | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Dr. Mingjie Wei | Biochemistry | Best Researcher Award

Doctor at Hubei University of Science and Technology, China

Dr. Mingjie Wei is a dedicated researcher and innovator in the fields of fluorescence sensors, bioimaging, organocatalysis, and drug design. With a solid foundation in chemistry and years of progressive experience across academic and industrial research settings, Dr. Wei has made meaningful contributions to chemical sciences. His research efforts are underscored by high-impact publications, patents, and leadership roles, positioning him as a promising figure in modern chemical innovation and translational science.

profile

scopus

Education

Dr. Wei began his academic journey in chemistry at Hainan University, where he earned his bachelor’s degree in 2010 under the supervision of Prof. Shiming Deng. He then pursued a master’s degree at Hunan Normal University, graduating in 2013, under the mentorship of Prof. Youyu Zhang and as part of Academician Yao Shouzhuo’s prestigious research team. His doctoral studies were completed at Sun Yat-sen University in 2021, where he worked under Prof. Le Li, focusing on cutting-edge topics in organocatalysis and fluorescence-based detection techniques.

Experience

Dr. Wei’s professional trajectory spans both academia and industry. He is currently a postdoctoral researcher at Guangzhou University under the guidance of Prof. Li Niu (since May 2024). Prior to this, he served as a high-level faculty member and master’s supervisor at Hubei University of Science and Technology from 2022, playing a critical role in teaching and mentoring graduate students. His industrial experience includes serving as R&D Director at Dongguan Biotechnology Development Co., Ltd. (2021–2022) and Project Manager at HEC Pharmaceutical Industry (2013–2016), where he led the development of several innovative drug and sensor technologies. He also contributed as a research assistant at Sun Yat-sen University (2016–2017), building further expertise in analytical chemistry.

Research Interest

Dr. Wei’s research interests are rooted in interdisciplinary chemistry. He focuses on fluorescence sensors and bioimaging, particularly for real-time detection of biological and environmental targets. His work also delves into organocatalysis and rational drug design, combining synthetic chemistry with molecular diagnostics. Through novel probe development and mechanistic studies, he aims to bridge the gap between chemical innovation and biomedical applications. His projects often emphasize sensitivity, selectivity, and biocompatibility—key metrics for translational success.

Award

Dr. Wei has been recognized for his academic and scientific excellence through multiple competitive grants and fellowships. These include the prestigious China Postdoctoral Science Foundation Award (2024M760620), Hubei Science and Technology Program grant (2022CFB781), and a Doctoral Startup Fund Project from Hubei University of Science and Technology. Additionally, he leads a university-level teaching reform project, further demonstrating his commitment to pedagogical excellence alongside research.

Publication

Dr. Wei has authored multiple peer-reviewed articles in high-impact journals. Below are seven select publications, showcasing his diverse research contributions:

Chem. Eng. J. (2025) – Co-authored a study on nanomaterials for environmental detection, cited by 12 articles.

Sci. China Chem. (2025) – Investigated advanced fluorescence probes, cited by 9 articles.

J. Colloid Interface Sci. (2025) – Developed biosensing platforms with clinical relevance, cited by 6 articles.

J. Colloid Interface Sci. (2023) – Explored novel colloidal interactions for sensor enhancement, cited by 18 articles.

Angew. Chem. Int. Ed. (2021) – Contributed to catalyst development for selective transformations, cited by 27 articles.

Spectrochim. Acta A (2024) – Published on spectroscopic methods in analyte detection, cited by 5 articles.

Anal. Methods (2017) – Designed a fluorescence-based method for metal ion detection, cited by 22 articles.

These publications reflect Dr. Wei’s consistent scholarly output and his ability to address diverse challenges in analytical and synthetic chemistry.

Conclusion

Dr. Mingjie Wei exemplifies the qualities of a distinguished researcher — scientific excellence, innovative spirit, and a commitment to translational impact. His robust academic foundation, rich professional experience, and outstanding scholarly output position him as a highly deserving candidate for the Best Researcher Award. Recognizing Dr. Wei would not only honor his individual achievements but also encourage continued innovation in chemical and biomedical sciences.

 

Dilek Gungor | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Mr. Dilek Gungor | Biochemistry | Best Researcher Award

Postdoctoral Researcher at Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey

Dilek Güngör is a researcher in forensic biochemistry and nanomedicine with a strong academic background and multidisciplinary experience. Her work focuses on innovative drug delivery systems, particularly in combating antimicrobial resistance. Through research roles at both national institutions and internationally renowned universities, she has established a profile marked by scientific curiosity, methodical rigor, and impactful contributions to pharmaceutical and forensic sciences.

profile

orcid

Education

Dilek completed her Ph.D. in Nanotechnology and Nanomedicine at Hacettepe University in December 2024, where she focused on liposome-based co-delivery systems for antimicrobial peptides and antibiotics. Her doctoral studies included an international research stint at Rutgers University in the U.S., supported by TÜBİTAK 2214/A. She earned her M.Sc. in Biochemistry (Pharmacy) from Gazi University in February 2018 and her B.Sc. in Biochemistry with a specialization in Biotechnology from Ege University in June 2009. Her academic formation reflects a consistent commitment to molecular and pharmaceutical sciences, with thesis work investigating gene expressions in cancer and novel therapeutic delivery platforms.

Experience

Dilek has served as a Research Assistant at the Turkish National Police Academy across several departments since 2014, currently contributing to the Forensic Science Department. Between 2022 and 2023, she was a Visiting Scholar at Rutgers University’s Center for Dermal Research, deepening her expertise in transdermal drug delivery systems. Her experience spans over a decade of applied biochemical research, including project leadership and interdisciplinary collaboration. She has demonstrated a capacity to work at the intersection of academic research and forensic application, contributing to both scientific advancement and public service.

Research Interest

Her research interests include nanomedicine, forensic toxicology, and dermal drug delivery systems. She is particularly engaged in designing liposome-based systems for co-delivery of antimicrobial agents, with an emphasis on reducing antimicrobial resistance. Additionally, she investigates molecular markers in cancer diagnostics and has an emerging interest in biosensor technologies for forensic and clinical applications. Her research is characterized by translational intent, targeting real-world medical and forensic challenges through molecular innovation.

Awards

Dilek has been recognized with a TÜBİTAK 2214-A International Research Fellowship, allowing her to pursue advanced pharmaceutical research abroad. Earlier in her career, she contributed to a TÜBİTAK 2209-A project on biosensor development during her undergraduate studies. These fellowships underscore both her scientific promise and her capacity to lead cutting-edge research in nationally and internationally competitive contexts.

Publications

Among her notable works, her 2025 article, “Co-delivery of Azithromycin and Nisin through liposomes for skin infection to reduce antimicrobial drug resistance,” was published in the International Journal of Pharmaceutics and has begun receiving citations for its innovative approach to antimicrobial therapy. In 2024, she co-authored “Evaluation of the interactions between human stratum corneum and liposome formulations using QCM-D” in the Journal of Drug Delivery Science and Technology, highlighting her proficiency in advanced instrumentation. In 2020, she published two significant papers in the European Journal of Breast Health and the Athens Journal of Health and Medical Sciences, focusing on glutathione-related enzymes in breast cancer subtypes. Her earlier publication, “Sentetik uyuşturucular: Amfetamin örneği,” appeared in the Güvenlik Çalışmaları Dergisi in 2018 and reflects her forensic research contributions. Her most cited article is the 2025 IJPharm paper on liposomal drug delivery for antimicrobial resistance, which is increasingly referenced in pharmaceutical and clinical research circles.

Conclusion

Dr. Dilek Güngör exemplifies the qualities of an outstanding researcher through her interdisciplinary education, impactful publications, technical mastery, and sustained commitment to scientific advancement. Her ability to bridge the gap between laboratory research and real-world application, particularly in the areas of antimicrobial resistance and diagnostics, positions her as an ideal recipient of the Best Researcher Award. Her trajectory reflects both depth and breadth of expertise, making her a valuable asset to the scientific community at large